Cargando…

Hematological Events Potentially Associated with CDK4/6 Inhibitors: An Analysis from the European Spontaneous Adverse Event Reporting System

Cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors are a recent targeted therapy approved for patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 negative (HER2−) advanced breast cancer. Abemaciclib, palbociclib and ribociclib demonstrated great efficacy and saf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martins, Vera, Jesus, Mafalda, Pereira, Luísa, Monteiro, Cristina, Duarte, Ana Paula, Morgado, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610381/ https://www.ncbi.nlm.nih.gov/pubmed/37895811 http://dx.doi.org/10.3390/ph16101340

Ejemplares similares

Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System
por: Rafaniello, Concetta, et al.
Publicado: (2021)

Peripheral Neuropathy Potentially Associated to Poly (ADP-Ribose) Polymerase Inhibitors: An Analysis of the Eudravigilance Database
por: Jesus, Mafalda, et al.
Publicado: (2023)

Quality of Spontaneous Reports of Adverse Drug Reactions Sent to a Regional Pharmacovigilance Unit
por: Salvador, Mário Rui, et al.
Publicado: (2022)

Management of Hematologic Adverse Events Associated With Immune Checkpoint Inhibitors
por: Rogers, Barbara Barnes, et al.
Publicado: (2021)

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
por: Kato, Yamato, et al.
Publicado: (2015)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
por: Han, Nayoung, et al.
Publicado: (2021)

META-INSTI: metabolic adverse events following integrase strand transfer inhibitor administration in spontaneous adverse event reports
por: Murray, Milena M, et al.
Publicado: (2023)

106. META-INSTI: Metabolic Adverse Events Following Integrase Strand Transfer Inhibitor Administration in Spontaneous Adverse Event Reports
por: Murray, Milena M, et al.
Publicado: (2020)

Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System
por: Barbieri, Maria Antonietta, et al.
Publicado: (2023)

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
por: Zhuang, Junling, et al.
Publicado: (2020)

Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting
por: Ali, Ayad K, et al.
Publicado: (2012)

Pattern of adverse events induced by aflibercept and ranibizumab: A nationwide spontaneous adverse event reporting database, 2007–2016
por: Ha, Dongmun, et al.
Publicado: (2019)

Sustained Viral Response and Hematological Adverse Events in Children With Chronic Hepatitis C
por: Vigano, Alessandra, et al.
Publicado: (2012)

Delayed Adverse Events after Procedural Sedation in Pediatric Patients with Hematologic Malignancies
por: Joo, Jin, et al.
Publicado: (2022)

Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review
por: Omar, Nabil E., et al.
Publicado: (2020)

Adverse Event Profiles of PARP Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS
por: Tian, Xiaojiang, et al.
Publicado: (2022)

Adverse Hematological and Non-Hematological Events in Patients With Relapsed/Refractory Multiple Myeloma That Are Responsive to Daratumumab, Pomalidomide and Dexamethasone
por: Alkharabsheh, Omar, et al.
Publicado: (2023)

Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
por: Toki, Tadashi, et al.
Publicado: (2018)

Clinical and Hematological Predictors of High-Grade Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors
por: Manne, Ashish, et al.
Publicado: (2021)

Spontaneously Reported Hepatic Adverse Drug Events in Korea: Multicenter Study
por: Kwon, Hee, et al.
Publicado: (2012)

A Standardized Dataset of a Spontaneous Adverse Event Reporting System
por: Khaleel, Mohammad Ali, et al.
Publicado: (2022)

Commentary: Adverse event profiles of PARP inhibitors: analysis of spontaneous reports submitted to FAERS
por: Schilder, Jeanne M., et al.
Publicado: (2023)

Nasogastric/nasoenteric tube-related adverse events: an integrative review
por: Motta, Ana Paula Gobbo, et al.
Publicado: (2021)

Hospital deaths and adverse events in Brazil
por: Martins, Mônica, et al.
Publicado: (2011)

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Hematological Adverse Events with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review with Meta-Analysis
por: Kronick, Olivia, et al.
Publicado: (2023)

Sustained Viral Response and Hematological Adverse Events During Chronic Hepatitis C Infection Treatment
por: El-Shabrawi, Mortada, et al.
Publicado: (2012)

Adverse events after pleurodesis in patients with malignant pleural effusion
por: Terra, Ricardo Mingarini, et al.
Publicado: (2020)

Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating Scales
por: Widschwendter, Christian G., et al.
Publicado: (2015)

Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs
por: Rydberg, Diana M, et al.
Publicado: (2018)

Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan
por: Kanbayashi, Yuko, et al.
Publicado: (2023)

Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors: A Systematic Literature Review and Meta-Analysis
por: Ohashi, Takuma, et al.
Publicado: (2023)

Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
por: Thill, Marc, et al.
Publicado: (2018)

Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events
por: Yu, Yue, et al.
Publicado: (2016)

Hematological Adverse events and Sustained Viral Response in Children Undergoing Therapy for Chronic Hepatitis C Infection
por: Pawlowska, Malgorzata, et al.
Publicado: (2011)

Hematologic adverse events reported after COVID-19 vaccination in the Philippines: A national database study
por: Mesina, Flordeluna Z., et al.
Publicado: (2023)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)

Rising Cyclin-CDK Levels Order Cell Cycle Events
por: Oikonomou, Catherine, et al.
Publicado: (2011)

CDK modulation coordinates G(1) events after S phase
por: Lacefield, Soni
Publicado: (2014)

CDK12 Activity-Dependent Phosphorylation Events in Human Cells
por: Bartkowiak, Bartlomiej, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tvj6nesrkoh9s4skbp8mc53l2f